ArticlePharmaceutics2022

Long-Acting Thioredoxin Ameliorates Doxorubicin-Induced Cardiomyopathy via Its Anti-Oxidative and Anti-Inflammatory Action.

Ryota Murata et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.